Market Tracker

05/22 5:16pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.75
Delayed Data
As of May 22
 +0.04 / +1.48%
Today’s Change
2.61
Today|||52-Week Range
16.55
-20.75%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.71
Today’s open2.70
Day’s range2.66 - 2.77
Volume62,754
Average volume (3 months)101,077
Market cap$65.3M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
AVDXAvant Diagnostics In...-0.04-7.25%
GBIMGlobeImmune Inc-0.16-2.12%
GBSNUGreat Basin Scientif...0.000.00%
TROVUTrovagene Inc0.000.00%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts